Please assess the completion status of the following clinical trial:

Trial Title: Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient with respiratory failure due to primary pulmonary pathology.~* Patient who is selected for BiPAP or CPAP by the health care provider~Exclusion Criteria:~* Age \<18 years.~* Respiratory failure due to non-pulmonary pathology.~* Impaired consciousness (Glasgow coma scale \<10).~* Patients with contraindications of NIV.~* Severe upper gastrointestinal bleeding.~* Chest trauma.~* Agitated or violent patient.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Aerosol-reducing Mask (Type: None): The participant will be placed on BIPAP using the aerosol-reducing mask. In the case where the patient is located in a care area where BIPAP is prohibited with a standard mask, they will assigned the aerosol-reducing mask.
- Standard Mask (Type: None): The patient will be placed on BIPAP using the standard mask. In the case where the patient is located in a care area where BIPAP is prohibited with a standard mask, they will assigned the aerosol-reducing mask.

Based on this trial design, predict the completion outcome and termination type (if applicable).